Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shahid, Muhammad | - |
dc.contributor.author | Gull, Nicole | - |
dc.contributor.author | Yeon, Austin | - |
dc.contributor.author | Cho, Eunho | - |
dc.contributor.author | Bae, Jooeun | - |
dc.contributor.author | Yoon, Hyun Seok | - |
dc.contributor.author | You, Sungyong | - |
dc.contributor.author | Yoon, Hana | - |
dc.contributor.author | Kim, Minjung | - |
dc.contributor.author | Berman, Benjamin P. | - |
dc.contributor.author | Kim, Jayoung | - |
dc.date.available | 2021-01-06T06:40:23Z | - |
dc.date.created | 2021-01-06 | - |
dc.date.issued | 2018-03 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/79632 | - |
dc.description.abstract | Interstitial cystitis (IC) is a chronic urinary tract disease that is characterized by unpleasant sensations, such as persistent pelvic pain, in the absence of infection or other identifiable causes. We previously performed comprehensive metabolomics profiling of urine samples from IC patients using nuclear magnetic resonance and gas-chromatography/mass spectrometry and found that urinary a-oxoglutarate (alpha-OG), was significantly elevated. alpha-OG, a tricarboxylic acid (TCA) cycle intermediate, reportedly functions to suppress the proliferation of immortalized normal human bladder epithelial cells. Here, we identified AT-rich interactive domain 1 A (ARID1A), a key chromatin remodeler, as being hypomethylated and upregulated by alpha-OG treatment. This was done through EPIC DNA methylation profiling and subsequent biochemical approaches, including quantitative RT-PCR and western blot analyses. Furthermore, we found that alpha-OG almost completely suppresses ten-eleven translocation (TET) activity, but does not affect DNA methyltransferase (DNMT) activity. Altogether, our studies reveal the potential role of alpha-OG in epigenetic remodeling through its effects on ARID1A and TET expression in the bladder. This may provide a new possible therapeutic strategy in treating IC. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.relation.isPartOf | SCIENTIFIC REPORTS | - |
dc.title | Alpha-oxoglutarate inhibits the proliferation of immortalized normal bladder epithelial cells via an epigenetic switch involving ARID1A | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000427366200035 | - |
dc.identifier.doi | 10.1038/s41598-018-22771-2 | - |
dc.identifier.bibliographicCitation | SCIENTIFIC REPORTS, v.8 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85044212661 | - |
dc.citation.title | SCIENTIFIC REPORTS | - |
dc.citation.volume | 8 | - |
dc.contributor.affiliatedAuthor | Kim, Jayoung | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | INTERSTITIAL-CYSTITIS | - |
dc.subject.keywordPlus | ANTIPROLIFERATIVE FACTOR | - |
dc.subject.keywordPlus | UROTHELIAL CARCINOMA | - |
dc.subject.keywordPlus | SYMPTOMS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.subject.keywordPlus | BIOMARKERS | - |
dc.subject.keywordPlus | NETWORKS | - |
dc.subject.keywordPlus | DATABASE | - |
dc.subject.keywordPlus | DISEASE | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.